Project Details
Description
The Gordon Lab will be looking at pre-clinical experiments with MEK inhibitors in cell lines and patient samples with apoptosis by Annexin V or the biologic end point. These experiments will be conducted by Sheila Prachand, Research Lab Manager.
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/13 → 8/31/15 |
Funding
- Tufts Medical Center, Inc. (5010960-SERV // R01CA164311)
- National Cancer Institute (5010960-SERV // R01CA164311)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.